High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23

Jens Frederik DahlerupDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; Correspondence[email protected]

Bent A. JacobsenDepartment of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark;

Janneke van der WoudeDepartment of Gastroenterology and Hepatology, Erasmus MC Rotterdam, Rotterdam, the Netherlands;

Lars-Åke BarkDepartment of Gastroenterology and Hepatology, Karolinska University Hospital, Stockholm, Sweden;

Lars L. ThomsenPharmacosmos A/S, Holbaek, Denmark;

Stefan LindgrenGastroenterology Division, Department of Clinical Sciences, Lund University, University Hospital Skane, Malmö, Sweden

Your download is now in progress and you may close this window